Subject
Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry
Reference58 articles.
1. Inhibition of dipeptidyl peptidase-4: the mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes;Smushkin;Diab. Metab. Synd. Obes. Targ. Thera.,2009
2. Alogliptin: a new addition to the class of DPP-4 inhibitors;Andukuri;Diab. Metab. Synd. Obes Targ. Thera.,2009
3. Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors;Kurukulasuriya;Cardiovas. Diab.,2010
4. Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
5. Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV;Feng;J. Med. Chem.,2007